The studies proposed will examine three aspects of cytokine interactions in rheumatoid arthritis (RA): 1) the role of cytokine antagonism and synergy in the pathogenesis of RA; 2) the regulation of GM-CSF production in the synovium as well as the role of GM-CSF and its inhibitor(s) in synovial inflammation and in stimulating proliferation of pluripotential cells; and 3) the location and environment of cytokine producing cells in the rheumatoid synovium. For the first project, three indices of synoviocyte activation (collagenase production, proliferation, and HLA-DR expression) will be used to test combinations of cytokines for synergy and antagonism. In preliminary experiments TNF-alpha and IFN-gamma antagonized each other's activating effects on synoviocytes. This and other negative interactions might be important homeostatic control mechanisms in the synovium. The mechanism of mutual antagonism between IFN-gamma and TNF-alpha will be investigated by determining the effect of TNF-alpha and IFN-gamma on surface receptor binding, expression, and internalization and measuring cytokine mediated changes in the rate of HLA-DR gene transcription and mRNA degradation. The second set of experiments will focus on the role of GM-CSF and GM-CSF inhibitors in RA. Ribonuclease protection assays will be used to study GM-CSF mRNA regulation in cultured synoviocytes and other synovial tissue cells while immuno- and bioassays will be used to measure secreted protein. A modified version of a PBM GM-CSF bioassay developed in our laboratory will be used to detect pluripotential cells in the synovium. The role of GM-CSF in synovial hyperplasia will be investigated by measuring the ability of CSFs to expand and differentiate pluripotential cells that reside in the tissue. Finally, in situ hybridization of RA synovial tissue frozen sections will be used to identify and localize cytokine producing cells in the synovium.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR040525-02
Application #
3160919
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1990-08-31
Project End
1995-06-30
Budget Start
1991-07-01
Budget End
1992-06-30
Support Year
2
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Zvaifler, N J; Tsai, V; Alsalameh, S et al. (1997) Pannocytes: distinctive cells found in rheumatoid arthritis articular cartilage erosions. Am J Pathol 150:1125-38
Lindsey, J D; Kashiwagi, K; Boyle, D et al. (1996) Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells. Curr Eye Res 15:869-75
Firestein, G S; Nguyen, K; Aupperle, K R et al. (1996) Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 149:2143-51
Zvaifler, N J (1995) Macrophages and the synovial lining. Scand J Rheumatol Suppl 101:67-75
Firestein, G S; Yeo, M; Zvaifler, N J (1995) Apoptosis in rheumatoid arthritis synovium. J Clin Invest 96:1631-8
Zvaifler, N J (1995) Rheumatoid arthritis. The multiple pathways to chronic synovitis. Lab Invest 73:307-10
Zvaifler, N J; Boyle, D; Firestein, G S (1994) Early synovitis--synoviocytes and mononuclear cells. Semin Arthritis Rheum 23:11-6
Zvaifler, N J; Firestein, G S (1994) Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum 37:783-9
Schumacher Jr, H R; Bautista, B B; Krauser, R E et al. (1994) Histological appearance of the synovium in early rheumatoid arthritis. Semin Arthritis Rheum 23:3-10
Firestein, G S; Boyle, D L; Yu, C et al. (1994) Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 37:644-52

Showing the most recent 10 out of 21 publications